Journal of Data Science

Approximately 15% of adults in the United States (U.S.) are afflicted with chronic kidney disease (CKD). For CKD patients, the progressive decline of kidney function is intricately related to hospitalizations due to cardiovascular disease and eventual “terminal” events, such as kidney failure and mortality. To unravel the mechanisms underlying the disease dynamics of these interdependent processes, including identifying influential risk factors, as well as tailoring decision-making to individual patient needs, we develop a novel Bayesian multivariate joint model for the intercorrelated outcomes of kidney function (as measured by longitudinal estimated glomerular filtration rate), recurrent cardiovascular events, and competing-risk terminal events of kidney failure and death. The proposed joint modeling approach not only facilitates the exploration of risk factors associated with each outcome, but also allows dynamic updates of cumulative incidence probabilities for each competing risk for future subjects based on their basic characteristics and a combined history of longitudinal measurements and recurrent events. We propose efficient and flexible estimation and prediction procedures within a Bayesian framework employing Markov Chain Monte Carlo methods. The predictive performance of our model is assessed through dynamic area under the receiver operating characteristic curves and the expected Brier score. We demonstrate the efficacy of the proposed methodology through extensive simulations. Proposed methodology is applied to data from the Chronic Renal Insufficiency Cohort study established by the National Institute of Diabetes and Digestive and Kidney Diseases to address the rising epidemic of CKD in the U.S.

Recent studies observed a surprising concept on model test error called the double descent phenomenon where the increasing model complexity decreases the test error first and then the error increases and decreases again. To observe this, we work on a two-layer neural network model with a ReLU activation function designed for binary classification under supervised learning. Our aim is to observe and investigate the mathematical theory behind the double descent behavior of model test error for varying model sizes. We quantify the model size by the ration of number of training samples to the dimension of the model. Due to the complexity of the empirical risk minimization procedure, we use the Convex Gaussian MinMax Theorem to find a suitable candidate for the global training loss.

When comparing two survival curves, three tests are widely used: the Cox proportional hazards test, the logrank test, and the Wilcoxon test. Despite their popularity in survival data analysis, there is no clear clinical interpretation especially when the proportional hazard assumption is not valid. Meanwhile, the restricted mean survival time (RMST) offers an intuitive and clinically meaningful interpretation. We compare these four tests with regards to statistical power under many configurations (e.g., proportional hazard, early benefit, delayed benefit, and crossing survivals) with data simulated from the Weibull distributions. We then use an example from a lung cancer trial to compare their required sample sizes. As expected, the CoxPH test is more powerful than others when the PH assumption is valid. The Wilcoxon test is often preferable when there is a decreasing trajectory in the event rate as time goes. The RMST test is much more powerful than others when a new treatment has early benefit. The recommended test(s) under each configuration are suggested in this article.

Extensive literature has been proposed for the analysis of correlated survival data. Subjects within a cluster share some common characteristics, e.g., genetic and environmental factors, so their time-to-event outcomes are correlated. The frailty model under proportional hazards assumption has been widely applied for the analysis of clustered survival outcomes. However, the prediction performance of this method can be less satisfactory when the risk factors have complicated effects, e.g., nonlinear and interactive. To deal with these issues, we propose a neural network frailty Cox model that replaces the linear risk function with the output of a feed-forward neural network. The estimation is based on quasi-likelihood using Laplace approximation. A simulation study suggests that the proposed method has the best performance compared with existing methods. The method is applied to the clustered time-to-failure prediction within the kidney transplantation facility using the national kidney transplant registry data from the U.S. Organ Procurement and Transplantation Network. All computer programs are available at https://github.com/rivenzhou/deep_learning_clustered.

Abstract: Mixture of Weibull distributions has wide application in modeling of heterogeneous data sets. The parameter estimation is one of the most important problems related to mixture of Weibull distributions. In this pa per, we propose a L-moment estimation method for mixture of two Weibull distributions. The proposed method is compared with maximum likelihood estimation (MLE) method according to the bias, the mean absolute error, the mean total error and completion time of the algorithm (time) by sim ulation study. Also, applications to real data sets are given to show the flexibility and potentiality of the proposed estimation method. The com parison shows that, the proposed method is better than MLE method.

In causal mediation analyses, of interest are the direct or indirect pathways from exposure to an outcome variable. For observation studies, massive baseline characteristics are collected as potential confounders to mitigate selection bias, possibly approaching or exceeding the sample size. Accordingly, flexible machine learning approaches are promising in filtering a subset of relevant confounders, along with estimation using the efficient influence function to avoid overfitting. Among various confounding selection strategies, two attract growing attention. One is the popular debiased, or double machine learning (DML), and another is the penalized partial correlation via fitting a Gaussian graphical network model between the confounders and the response variable. Nonetheless, for causal mediation analyses when encountering high-dimensional confounders, there is a gap in determining the best strategy for confounding selection. Therefore, we exemplify a motivating study on the human microbiome, where the dimensions of mediator and confounders approach or exceed the sample size to compare possible combinations of confounding selection methods. By deriving the multiply robust causal direct and indirect effects across various hypotheses, our comprehensive illustrations offer methodological implications on how the confounding selection impacts the final causal target parameter estimation while generating causality insights in demystifying the “gut-brain axis”. Our results highlighted the practicality and necessity of the discussed methods, which not only guide real-world applications for practitioners but also motivate future advancements for this crucial topic in the era of big data.

Cellular deconvolution is a key approach to deciphering the complex cellular makeup of tissues by inferring the composition of cell types from bulk data. Traditionally, deconvolution methods have focused on a single molecular modality, relying either on RNA sequencing (RNA-seq) to capture gene expression or on DNA methylation (DNAm) to reveal epigenetic profiles. While these single-modality approaches have provided important insights, they often lack the depth needed to fully understand the intricacies of cellular compositions, especially in complex tissues. To address these limitations, we introduce EMixed, a versatile framework designed for both single-modality and multi-omics cellular deconvolution. EMixed models raw RNA counts and DNAm counts or frequencies via allocation models that assign RNA transcripts and DNAm reads to cell types, and uses an expectation-maximization (EM) algorithm to estimate parameters. Benchmarking results demonstrate that EMixed significantly outperforms existing methods across both single-modality and multi-modality applications, underscoring the broad utility of this approach in enhancing our understanding of cellular heterogeneity.

Predicting the timing and occurrence of events is a major focus of data science applications, especially in the context of biomedical research. Performance for models estimating these outcomes, often referred to as time-to-event or survival outcomes, is frequently summarized using measures of discrimination, in particular time-dependent AUC and concordance. Many estimators for these quantities have been proposed which can be broadly categorized as either semi-parametric estimators or non-parametric estimators. In this paper, we review the mathematical construction of the two classes of estimators and compare their behavior. Importantly, we identify a previously unknown feature of the class of semi-parametric estimators that can result in vastly overoptimistic out-of-sample estimation of discriminative performance in common applied tasks. Although these semi-parametric estimators are popular in practice, the phenomenon we identify here suggests that this class of estimators may be inappropriate for use in model assessment and selection based on out-of-sample evaluation criteria. This is due to the semi-parametric estimators’ bias in favor of models that are overfit when using out-of-sample prediction criteria (e.g. cross-validation). Non-parametric estimators, which do not exhibit this behavior, are highly variable for local discrimination. We propose to address the high variability problem through penalized regression splines smoothing. The behavior of various estimators of time-dependent AUC and concordance are illustrated via a simulation study using two different mechanisms that produce overoptimistic out-of-sample estimates using semi-parametric estimators. Estimators are further compared using a case study using data from the National Health and Nutrition Examination Survey (NHANES) 2011–2014.